Belgin ALASEHIRLI, Elif OGUZ, Şenay KOÇAKOĞLU, Dursun ÇADIRCI, Elif Burcu Yavuz DAĞLIOĞLU

Asistan Hekimlerin Olumsuz İlaç Reaksiyonları Konusundaki Bilgi ve Tutumları

Amaç: DSÖ, evrensel mesajında tüm sağlık hizmeti sağlayıcılarına, Advers İlaç Reaksiyonlarının (AİR) raporlanması sayesinde binlerce hastanın hayatının kurtarılabileceğini bildirmiştir. Bu çalışmada üniversite hastanemizdeki asistan hekimlerin AİR ve farmakovijilans konusundaki bilgi düzeylerini ve tutumlarını değerlendirmeyi amaçladık. Gereç ve Yöntem: Bu prospektif çalışma, Harran Üniversitesi Hastanesi'nde çalışmaya katılmayı kabul eden 88 asistan hekim üzerinde 14 sorudan oluşan bir anket formuyla gerçekleştirildi. Çalışmaya Harran Üniversitesi Tıp Fakültesi Etik Kurulu onayının alınmasından sonra başlandı. Anketin sonuçları SPSS 18.0 paket programı kullanılarak frekans ve yüzde testleri ile değerlendirildi. Bulgular: AİR'lerin kesin tanımı doktorların %51,1’i tarafından doğru bir şekilde işaretlenmiştir. Hekimlerin çoğu (%69,3) hiçbir zaman AİR raporlaması yapmadığını belirtmiştir. AİR raporlaması yapmanın sağlık profesyonellerinin sorumluluğu olmadığını düşünen katılımcıların oranı %9,1’dir. Hekimlerin sadece %6,8’inin AİR raporlaması hakkında mesleki bilgi veya eğitim aldığı gözlemlenmiştir. Hekimlerin %72,7’si Türkiye'de AİR'in ciddi bir sorun olduğunu düşünmektedir. Sonuç: Bu çalışma hastanemizde çalışan asistanların AİR raporlaması konusundaki bilgi ve tutum düzeylerinin yeterli olmadığını göstermiştir. AİR'lerin raporlanması konusunda sağlık uzmanları arasında farkındalığın artırılmasının önemli olduğuna ve durumun etkili ve periyodik eğitim yöntemleriyle iyileştirilebileceğine inanıyoruz.

Knowledge and Attitudes of Resident Physicians about Adverse Drug Reactions

Objective: WHO reported to all healthcare providers in its universal message thatthousands of patients’ lives could be saved by reporting adverse drug reactions(ADRs). In this study, we aimed to evaluate the knowledge levels and attitudes of theresident physicians about ADRs and pharmacovigilance in our university hospital.Methods: This prospective study was performed by a questionnaire form consisted of14 questions on 88 resident physicians who accepted to participate the study in HarranUniversity Hospital. The study was started after takening the approval of HarranUniversity Faculty of Medicine Ethics Committee. The results of the questionnairewere evaluated by using SPSS 18.0 package program by frequency and percentagetests.Results: The exact definition of ADRs is correctly marked by 51.1% of doctors. Mostof the physicians (69.3%) stated that they had never do ADR reporting. The rate of theparticipants who think that it is not the responsibility of the healthcare professionals tomake ADR reporting is 9.1%. It was observed that only 6.8% of the physiciansreceived professional information or training on ADR reporting. It was expressed by72.7% of physicians that ADR is a serious problem in Turkey.Conclusions: This study showed that the level of knowledge and attitude of residentphysicians working in our hospital about ADR reporting was not sufficient. Webelieve that it is important to raise awareness among the healthcare professionalsabout the ADR reporting and the situation can be improved by effective and periodicaltraining methods.

PDF

___

1. Farcas A, Bojita M. Adverse drug reactions in clinical practice: a causality assessment of a case of druginduced pancreatitis. J Gastrointestin Liver Dis. 2009;18(3):353-8.
2. World Health Organization. Quality A, Safety of Medicines T. Safety of medicines : a guide to detecting and reporting adverse drug reactions : why health professionals need to take action. Geneva: World Health Organization; 2002.
3. Passarelli MCG, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population. Drugs & aging. 2005;22(9):767-77.
4. Leape LL. Error in medicine. Jama. 1994;272(23):1851-7.
5. Aykaç E, editor Farmakovijilansa Bakış ve Türkiye Farmakovijilans Merkezinin Çalışmaları. 12 Ulusal Aile Hekimliği Kongresi; 15-19 May 2013; Kuşadası-Aydin.
6. Brewer T, Colditz GA. Postmarketing surveillance and adverse drug reactions: current perspectives and future needs. Jama. 1999;281(9):824-9.
7. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Bmj. 2004;329(7456):15-9.
8. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a metaanalysis of prospective studies. Jama. 1998;279(15):1200-5.
9. Ozcan G, Aykac E, Kasap Y, Nemutlu NT, Sen E, Aydinkarahaliloglu ND. Adverse drug reaction reporting pattern in Turkey: analysis of the national database in the context of the first pharmacovigilance legislation. Drugs-real world outcomes. 2016;3(1):33-43.
10.Dormann H, Muth-Selbach U, Krebs S, Criegee-Rieck M, Tegeder I, Schneider HT, et al. Incidence and costs of adverse drug reactions during hospitalisation. Drug safety. 2000;22(2):161-8.
11.Türkiye İlaç ve Tıbbi Cihaz Kurumu TÜFAM. İyi Farmakovijilans Uygulamaları (İFU) Kılavuzu Modül I– Advers ilaç reaksiyonlarının yönetimi ve bildirimi. 2014 [cited 2020 June 20]. Available from: https://www.titck.gov.tr/Dosyalar/Ilac/Farmakovijilans/%C4%B0FU%20Mod%C3%BCl%20I.pdf.
12.Waller PC. Making the most of spontaneous adverse drug reaction reporting. Basic & clinical pharmacology & toxicology. 2006;98(3):320-3.
13.Dhikav V, Singh S, Anand K. Adverse drug reaction monitoring in India. J Indian Acad Clin Med. 2004;5(1):27-33.
14.Şencan N, Altınkaynak M, Ferah I, Özyıldırım A, Ceylan EM, Clark PM. The knowledge and attitudes of physicians and nurses towards adverse event reporting and the effect of pharmacovigilance training: A hospital experience. Hacettepe Üniversitesi Eczacılık Fakültesi Dergisi. 2010; 1:25-40.
15.Ergün Y, Ergün TB, Toker E, Ünal E, Akben M. Knowledge attitude and practice of Turkish health professionals towards pharmacovigilance in a university hospital. International health. 2019;11(3):177-84.
16.Güner MD, Ekmekci PE. Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates. Journal of drug assessment. 2019;8(1):13-20.
17.Paveliu MS, Bengea-Luculescu S, Mihai T, Paveliu SF. Perception on adverse drug reaction reporting by physicians working in southern Romania. Maedica. 2013;8(1):17-25.
18.Singh J, Singh H, Rohilla R, Kumar R, Gautam C. Lack of awareness of pharmacovigilance among young health-care professionals in India: An issue requiring urgent intervention. International Journal of Applied and Basic Medical Research. 2018;8(3):158-63.
19.Stoynova V, Getov IN, Naseva EK, Lebanova HV, Grigorov EE. Physicians' knowledge and attitude towards adverse event reporting system and result to intervention--randomized nested trial among Bulgarian physicians. Medicinski Glasnik. 2013;10(2):365-72.
20.Altıntaş Aykan D, Nazik H, Ergün Y. Advers İlaç Reaksiyonları Spontan Bildirimlerinin Değerlendirilmesi: Klinik Farmakoloji Deneyimimiz. Kocaeli Tıp Dergisi. 2019;8(2):230-9.
21.Palaian S, Ibrahim MI, Mishra P. Health professionals' knowledge, attitude and practices towards pharmacovigilance in Nepal. Pharmacy practice. 2011; 9(4):228-35.
22.Khan SA, Goyal C, Chandel N, Rafi M. Knowledge, attitudes, and practice of doctors to adverse drug reaction reporting in a teaching hospital in India: An observational study. Journal of natural science, biology, and medicine. 2013;4(1):191-6.
23.Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC clinical pharmacology. 2009;9(1):14.
24.Fincham J. A statewide program to stimulate reporting of adverse drug reactions. Journal of pharmacy practice. 1989;2(4):239-44.
25.McGettigan P, Golden J, Conroy R, Arthur N, Feely J. Reporting of adverse drug reactions by hospital doctors and the response to intervention. British journal of clinical pharmacology. 1997;44(1):98-100.
26.Figueiras A, Herdeiro MT, Polónia J, Gestal-Otero JJ. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. Jama. 2006;296(9):1086-93.
27.Necho W, Worku A. Assessment of knowledge, attitude and practice of health professionals towards adverse drug reaction reporting and factors associated with reporting. J Pharmacovigilance. 2014;2(4):135. doi:10.4172/2329-6887.1000135
28.Asseray N, Ballereau F, Trombert-Paviot B, Bouget J, Foucher N, Renaud B, et al. Frequency and severity of adverse drug reactions due to self-medication: a cross-sectional multicentre survey in emergency departments. Drug safety. 2013;36(12):1159-68.
29.Schmiedl S, Rottenkolber M, Hasford J, Rottenkolber D, Farker K, Drewelow B, et al. Self-medication with over-the-counter and prescribed drugs causing adverse-drug-reaction-related hospital admissions: results of a prospective, long-term multi-centre study. Drug safety. 2014;37(4):225-35.

ISSN: 1309-3878
Yayın Aralığı: Yılda 3 Sayı
Başlangıç: 2009
Yayıncı: Düzce Üniversitesi Tıp Fakültesi Aile Hekimliği AD adına Yrd.Doç.Dr.Cemil Işık Sönmez